BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3065687)

  • 1. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
    Kloke O; May D; Wandl U; Niederle N
    Onkologie; 1988; 11 Suppl 2():41-5. PubMed ID: 3065687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
    Moormeier JA; Ratain MJ; Westbrook CA; Vardiman JW; Daly KM; Golomb HM
    J Natl Cancer Inst; 1989 Aug; 81(15):1172-4. PubMed ID: 2746669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon.
    Holmes R; Schwarz MA; Whiteside MG; Firkin FC
    Aust N Z J Med; 1988 Jun; 18(4):557-62. PubMed ID: 3196242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
    J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
    Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
    J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very low dose alpha-2b interferon for the treatment of hairy cell leukemia.
    Thompson JA; Kidd P; Rubin E; Fefer A
    Blood; 1989 May; 73(6):1440-3. PubMed ID: 2713488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].
    Niederle N; Doberauer C; Kloke O; Höffken K; Schmidt CG
    Klin Wochenschr; 1987 Jul; 65(14):706-12. PubMed ID: 3114551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
    Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia].
    Schwarzmeier JD; Wagner L; Prischl F; Schwabe M; Lion T; Micksche M; Köller U; Bernhart M; Fritz O; Seewann HL
    Klin Wochenschr; 1987 Jul; 65(14):699-705. PubMed ID: 3114550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin.
    Schiller JH; Hawkins MJ; O'Connell MJ; Sielaff K; Borden EC
    J Biol Response Mod; 1989 Jun; 8(3):252-61. PubMed ID: 2746297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.
    Rai KR; Davey F; Peterson B; Schiffer C; Silver RT; Ozer H; Golomb H; Bloomfield CD
    Leukemia; 1995 Jul; 9(7):1116-20. PubMed ID: 7630181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
    Ratain MJ; Golomb HM; Bardawil RG; Vardiman JW; Westbrook CA; Kaminer LS; Lembersky BC; Bitter MA; Daly K
    Blood; 1987 Mar; 69(3):872-7. PubMed ID: 3814819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
    Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
    J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
    Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF; Estey EH; Keating MJ; Kurzrock R
    Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment.
    Troussard X; Flandrin G
    Leuk Lymphoma; 1994; 14 Suppl 1():99-105. PubMed ID: 7820062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.